| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.04 | 0.4 |